Mind Medicine (MindMed) Inc. Announces Proposed Public Offering

NEW YORK -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it intends to offer and sell, subject to market conditions, common shares and, to certain investors, pre-funded warrants to purchase common shares in an underwritten public offering. All of the common shares and pre-funded warrants are being offered by MindMed. Read More

Mind Medicine (MindMed) Inc. Announces Proposed Public Offering

Mind Medicine (MindMed) Inc. Announces Proposed Public Offering

Mind Medicine (MindMed) Inc. Announces Proposed Public Offering

Mind Medicine (MindMed) Inc. Announces Proposed Public Offering

Mind Medicine (MindMed) Inc. Announces Proposed Public Offering